Langmu Medical's High-Oxygen-Permeable Silicone Successfully Listed in National 'Challenge-Based Innovation' Program, Empowering High-Quality Development in Ophthalmic Healthcare

Sep 17, 2025 09:01 CST Updated 09:01

Purevision Medical

Developer of Ophthalmic Disease Treatment Products

Purevision Medical Successfully Selected for the "Biomedical Materials Innovation Task List (Batch 2)" Recently Announced by the Ministry of Industry and Information Technology and the National Medical Products Administration, Thanks to Its Core Technology Advantages. The Highly Oxygen-Permeable Silicone Material Featured in This List Combines High Oxygen Permeability, High Porosity, and Excellent Biocompatibility, Making It Widely Applicable in Clinical Fields Such as Ophthalmology. This Achievement Not Only Demonstrates Purevision Medical's Innovative Strength in the Research and Development of Biomedical Polymer Materials but Also Marks a Significant Step Forward for the Company in Promoting Minimally Invasive Ophthalmic Treatments and the Large-Scale Application of Biomaterials.

Danlu Capital always focuses on the frontier technologies and clinical value in the healthcare industry. We will continue to work with Purevision Medical to promote the clinical application of innovative technologies and contribute to the high-quality development of the healthcare industry.

Original link:

Some content and images in the article are from the Internet. If there is any infringement, please inform us to delete.

Data and FiguresPurevision MedicalSource: Purevision Medical

DanLuCapital